Release of brain-specific creatine kinase and neuron-specific enolase into cerebrospinal fluid after hypothermic and normothermic cardiopulmonary bypass in coronary artery surgery

被引:10
作者
Kaukinen, L
Porkkala, H
Kaukinen, S
Pehkonen, E
Kärkelä, J
Aaran, RK
Tarkka, M
机构
[1] Tampere Univ Hosp, Dept Anaesthesia & Intens Care, FIN-33521 Tampere, Finland
[2] Tampere Univ Hosp, Dept Cardiovasc Surg, FIN-33521 Tampere, Finland
[3] Univ Tampere, Sch Med, FIN-33101 Tampere, Finland
关键词
coronary artery bypass surgery; cardiopulmonary bypass; normothermic; hypothermic; neurologic outcome; cerebrospinal fluid enzymes;
D O I
10.1034/j.1399-6576.2000.440402.x
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
Background: Coronary artery bypass (CABG) surgery is successfully managed with normothermic cardiopulmonary bypass (CPB) using warm blood cardioplegia. The lack of the protective effect of hypothermia, however, might make the central nervous system vulnerable. Methods: Thirty-six patients were randomized into normothermic CPB (36-37 degrees C) (NTCPB group, n=18) and hypothermic CPB (28 degrees C) (HTCPB group, n=18) in order to examine whether normothermic or hypothermic CPB induces the release of the intracellular brain enzymes, creatine kinase (CK), its brain-specific isoenzyme (CK-BB), and neuron-specific enolase (NSE) into cerebrospinal fluid (CSF). In addition, clinical neurologic examination and neuropsychologic assessment were done preoperatively, 5 d and 11-23 mo postoperatively. Results: One patient in each group suffered a stroke after surgery. Two patients in the normothermic group had minor neurologic complications. The cognitive decline after operation was similar in the NTCPB and HTCPB groups. CSF enzymes from normothermic and hypothermic CABG patients without gross neurologic complications were not significantly higher than CSF enzymes from orthopaedic reference patients. CABG patients with neurologic complications had higher enzyme concentrations. Cognitive decline after the operation correlated statistically significantly with CSF enzyme concentrations in the NTCPB group, but not in the HTCPB group. Conclusion: CABG operation without major neurologic complication does not induce the release of CK, CK-BB or NSE enzymes into CSF, irrespective of whether the CPB is normothermic or hypothermic. (C) Acta Anaesthesiologica Scandinavica 44 (2000).
引用
收藏
页码:361 / 368
页数:8
相关论文
共 27 条
[11]   Depression and cognitive decline after coronary artery bypass grafting [J].
McKhann, GM ;
Borowicz, LM ;
Goldsborough, MA ;
Enger, C ;
Selnes, OA .
LANCET, 1997, 349 (9061) :1282-1284
[12]   The effect of temperature management during cardiopulmonary bypass on neurologic and neuropsychologic outcomes in patients undergoing coronary revascularization [J].
Mora, CT ;
Henson, MB ;
Weintraub, WS ;
Murkin, JM ;
Martin, TD ;
Craver, JM ;
Gott, JP ;
Guyton, RA .
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 1996, 112 (02) :514-522
[13]   STATEMENT OF CONSENSUS ON ASSESSMENT OF NEUROBEHAVIORAL OUTCOMES AFTER CARDIAC-SURGERY [J].
MURKIN, JM ;
NEWMAN, SP ;
STUMP, DA ;
BLUMENTHAL, JA .
ANNALS OF THORACIC SURGERY, 1995, 59 (05) :1289-1295
[14]  
Nygaard O, 1998, SCAND J CLIN LAB INV, V58, P183
[15]   Do blood levels of neuron-specific enolase and S-100 protein reflect cognitive dysfunction after coronary artery bypass? [J].
Rasmussen, LS ;
Christiansen, M ;
Hansen, PB ;
Moller, JT .
ACTA ANAESTHESIOLOGICA SCANDINAVICA, 1999, 43 (05) :495-500
[16]   Adverse cerebral outcomes after coronary bypass surgery [J].
Roach, GW ;
Kanchuger, M ;
Mangano, CM ;
Newman, M ;
Nussmeier, N ;
Wolman, R ;
Aggarwal, A ;
Marschall, K ;
Graham, SH ;
Ley, C ;
Ozanne, G ;
Mangano, DT .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 335 (25) :1857-1863
[17]  
Robinson M, 1990, J CARDIOPULM REHABIL, V10, P180
[18]   Serum and CSF levels of neuron-specific enolase (NSE) in cardiac surgery with cardiopulmonary bypass: a marker of brain injury? [J].
Schmitt, B ;
Bauersfeld, U ;
Schmid, ER ;
Tuchschmid, P ;
Molinari, L ;
Fanconi, S ;
Bandtlow, C .
BRAIN & DEVELOPMENT, 1998, 20 (07) :536-539
[19]  
SELLMAN M, 1993, THORAC CARDIOVASC SU, V41, P457
[20]  
SHAW PJ, 1987, Q J MED, V62, P259